Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples